Clinical management of postpartum hemorrhage: an integrative review
DOI:
https://doi.org/10.33448/rsd-v10i16.23363Keywords:
Hemorrhage; Postpartum Hemorrhage; TreatmentAbstract
Introduction: Postpartum hemorrhage is the cause of approximately 25% of all deaths of pregnant women worldwide and is responsible for a large proportion of severe maternal morbidities. Thus, we aimed to evaluate and synthesize the latest publications on the clinical treatment of this event. Methodology: This is an integrative review conducted from January to June 2021, which aimed to answer the following guiding question: "What is the recent evidence available in the literature on the clinical treatment of postpartum hemorrhage? The search considered the last 5 years and resulted in 150 articles, of which 12 were selected due to eligibility criteria. Results: All articles were randomized clinical trials and written in English, published in international journals. Regarding the countries of performance, 4 studies were performed in two or more countries and the others were performed in 7 different countries. Discussion: Oxytocin infusion is considered the gold standard for the treatment of postpartum hemorrhage. However, when there is unavailability or contraindication to the use of this drug, data on recommendations for second-line therapies are lacking. In this sense, other drugs such as methylergometrine, tranexamic acid, misoprostol, among others, may become advantageous. Conclusion: Due to the impact that this hemorrhage has on maternal health, the importance of identifying secondary strategies for its control is evident, demonstrating the appropriate routes of administration, safety and effectiveness of the drugs.
References
Alves, Á. L. L., Francisco, A. A., Osanan, G. C., & Vieira, L. B. (2020). Hemorragia pós-parto: Prevenção, diagnóstico e manejo não cirúrgico. FEBRASGO Position Statement, 5, 1–7.
Andrade, P. de O. N., Oliveira, S. C. de, Morais, S. C. R. V., Guedes, T. G., Melo, G. P. de, & Linhares, F. M. P. (2019). Validação de cenário de simulação clínica no manejo da hemorragia pós-parto. Revista Brasileira de Enfermagem, 72(3), 624–631. https://doi.org/10.1590/0034-7167-2018-0065
Baratieri, T., & Natal, S. (2019). Ações do programa de puerpério na atenção primária: Uma revisão integrativa. Ciência & Saúde Coletiva, 24(11), 4227–4238. https://doi.org/10.1590/1413-812320182411.28112017
Brenner, A., Shakur-Still, H., Chaudhri, R., Fawole, B., Arulkumaran, S., & Roberts, I. (2018). The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: An exploratory subgroup analysis of the WOMAN trial. BMC Pregnancy and Childbirth, 18, 215. https://doi.org/10.1186/s12884-018-1855-5
Campo Grande. (2021). Atenção à puérpera e ao recém-nascido: Orientações técnicas para profissionais 2021. SESAU.
Cecilia, M., Vijayaselvi, R., Bansal, R., Lakshmi, L., & Jose, R. (2018). Ten units intravenous oxytocin over 2-4 h is as effective as 30 units over 8-12 h in preventing postpartum hemorrhage after cesarean section: A randomized controlled trial. Indian Journal of Pharmacology, 50(5), 279–283. https://doi.org/10.4103/ijp.IJP_419_18
Colucci, G., Helsing, K., Biasiutti, F. D., Raio, L., Schmid, P., Tsakiris, D. A., Eberle, B., Surbek, D., Lämmle, B., & Alberio, L. (2018). Standardized management protocol in severe postpartum hemorrhage: A single-center study. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 24(6), 884–893. https://doi.org/10.1177/1076029618758956
Ducloy-Bouthors, A. S., Mercier, F. J., Grouin, J. M., Bayoumeu, F., Corouge, J., Le Gouez, A., Rackelboom, T., Broisin, F., Vial, F., Luzi, A., Capronnier, O., Huissoud, C., Mignon, A., & FIDEL working group. (2021). Early and systematic administration of fibrinogen concentrate in postpartum haemorrhage following vaginal delivery: The FIDEL randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), 1814–1823. https://doi.org/10.1111/1471-0528.16699
Dumont, A., Bodin, C., Hounkpatin, B., Popowski, T., Traoré, M., Perrin, R., & Rozenberg, P. (2017). Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: A randomised controlled trial in Benin and Mali. BMJ Open, 7(9), e016590. https://doi.org/10.1136/bmjopen-2017-016590
Durocher, J., Dzuba, I. G., Carroli, G., Morales, E. M., Aguirre, J. D., Martin, R., Esquivel, J., Carroli, B., & Winikoff, B. (2019). Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trial. PLOS ONE, 14(10), e0222981. https://doi.org/10.1371/journal.pone.0222981
Koch, D. M., & Rattmann, Y. D. (2019). Uso do misoprostol no tratamento da hemorragia pós-parto: Uma abordagem farmacoepidemiológica. Einstein (São Paulo), 18, 1–7. https://doi.org/10.31744/einstein_journal/2020AO5029
Li, B., Miners, A., Shakur, H., Roberts, I., & WOMAN Trial Collaborators. (2018). Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: A cost-effectiveness analysis of data from the WOMAN trial. The Lancet. Global Health, 6(2), e222–e228. https://doi.org/10.1016/S2214-109X(17)30467-9
OPAS. (2018). Recomendações assistenciais para prevenção, diagnóstico e tratamento da Hemorragia Obstétrica. OPAS.
Shady, N. W., Sallam, H. F., Elsayed, A. H., Abdelkader, A. M., Ali, S. S., Alanwar, A., & Abbas, A. M. (2019). The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: A randomized controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 32(11), 1806–1812. https://doi.org/10.1080/14767058.2017.1418316
Sweed, M., El-Said, M., Abou-Gamrah, A., & Ali, M. (2019). Comparison between 200, 400 and 600 microgram rectal misoprostol before cesarian section: A randomized clinical trial. The Journal of Obstetrics and Gynaecology Research, 45(3), 585–591. https://doi.org/10.1111/jog.13883
WOMAN Trial Collaborators. (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet (London, England), 389(10084), 2105–2116. https://doi.org/10.1016/S0140-6736(17)30638-4
Zargar, M., Nikbakht, R., & Ahmadi, M. (2018). The effect of tranexamic acid on preventing post-partum hemorrhage due to uterine atony: A triple-blind Randomized Clinical Trial. Current Clinical Pharmacology, 13(2), 136–139. https://doi.org/10.2174/1574884713666180507101002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Antonio Paulo Nunes da Silva; Maria Eduarda da Silva Dias; Pollyana Rodrigues Diniz; Valda Lúcia Moreira Luna; George Alessandro Maranhão Conrado; Pauliana Valéria Machado Galvão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
